Severe to Critical COVID 19 With Associated ARDS

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Severe to Critical COVID 19 With Associated ARDS trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

TerminatedPhase 2/3

NCT04750278

A Phase 2/3 Study to Evaluate FP-025 in Patients With Severe to Critical COVID 19

This is a Phase 2/3, randomized, double blind, placebo controlled, multicenter study to evaluate the efficacy and safety of FP-025 in adult patients with severe…

United States90 participantsStarted 2021-04-06

Treatment: FP-025 100 mg, FP-025 300 mg